BOCA RATON, Fla.–(BUSINESS WIRE)–SurGenTec®, a privately held spine and orthopedic technology company based in Boca Raton, FL, announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for ION™ Screw, its proprietary stand-alone spine fixation implant.
PRESS RELEASES
PRESS RELEASES
SurGenTec® Launches ION™ Screw, Smallest Posterior Spinal Fixation Implant, to Market After Receiving FDA Clearance
SurGenTec® Releases Whitepaper Featuring a Novel Decortication and Graft Delivery Technique for Minimally Invasive Spine Fusion Surgery
Minimally invasive (MIS) lumbar fusion has become a popular alternative to traditional methods of lumbar decompression and fusion. When compared with the open technique, the minimally invasive approach can result in decreased pain and blood loss as well as a shorter length of hospitalization. However, the narrower working channel in the MIS technique increases the difficulty of decortication and bone grafting.
This paper describes a novel set of instruments, the 3D GraftRasp System by SurGenTec, that physicians can use to help create an optimal environment to fuse the facet joints and lateral gutters during minimally invasive lumbar fusions. Retrospective clinical data from case reports are presented on 3 patients that underwent single level and multi-level MIS lumbar fusions utilizing the 3D GraftRasp System. The case reports show that the 3D GraftRasp System can provide a viable solution for physicians wanting to perform a minimally invasive procedure to achieve fusion while decorticating and packing bone graft around the facet joints and lateral gutters.
SurGenTec® Announces First-of-its-Kind FDA Clearance for its 3D GraftRasp System™ Including Key Spine Indications
The 3D GraftRasp System is the only device to receive FDA clearance that allows for both decortication of bone and the delivery of autograft, allograft or synthetic bone graft. It is approved for general orthopedic use and spine procedures. “In spine procedures, the transverse processes and facet joints may now be targeted in a more efficient and effective surgical technique pioneered by SurGenTec,” says Founder and CEO Travis Greenhalgh. The 3D GraftRasp System is ideal for use in posterolateral or intertransverse lumbar fusion cases.
SurGenTec® Announces FDA Clearance for Neurostimulation with ALARA™ Access Needle Kit
BOCA RATON, Fla.–(BUSINESS WIRE)–SurGenTec, a privately held spine and orthopedic technology company, announced today it has received FDA clearance for a neurostimulation indication for their ALARA Neuro Access Needle Kit. The ALARA system is used for targeting and assisting in cannulating a pedicle. Targeting needles are generally the first instrument used to perforate the pedicle wall before advancing a guidewire, tap or pedicle screw.
Clinical Launch of SurGenTec® GraftGun® System Prefilled with ViBone® a Resounding Success
BOCA RATON, Fla.–(BUSINESS WIRE)–SurGenTec® announced today the successful completion of the initial clinical launch of its new GraftGun bone graft delivery system combined with ViBone Viable Bone Matrix prefilled tubes. This early evaluation of the combined products was focused in the Minimally Invasive Spine (MIS) surgery field.
Ten Best New Spine Technologies for 2018
The ten companies with the BEST new spine care technologies for 2018 are: Augmedics, DiFusion Inc., Green Sun Medical, K2M, Inc., MiRus, LLC, Power T Handle, LLC, RTI Surgical, Inc., Simplify Medical, Inc., SurGenTec and Tyber Medical LLC.
SurGenTec’s ALARA™ Access Needle Awarded Best Spine Technology for 2018
SurGenTec® LLC, a South Florida based medical device company has been awarded the 2018 Orthopedics This Week Spine Technology Award and will be formally receiving their award during the 2018 North American Spine Society meeting. This year’s meeting will be held Sept. 26th -28th in Los Angeles, CA. The awarded technology from Surgentec’s product line is the unique and innovative ALARA™ access needle.